Medical News

RSS

Applied Spine Technologies awarded U.S. patents for 'Dynamic Spine Stabilizer' and 'Spring Junction'

Applied Spine Technologies, Inc., a medical device company focused on motion preservation of the lumbar spine, was awarded two new patents by the U.S. Patent and Trademark Office on May 11, 2010.

25 May 2010

KHN Consumer column: Insuring your health – College student health plans often get low marks

In this Kaiser Health News column, produced in collaboration with The Washington Post, Michelle Andrews writes: "Aaron Smith is learning the hard way that student health insurance has limits.

25 May 2010

U.S. Renal Care announces definitive agreements to acquire Dialysis Corporation of America

U.S. Renal Care, Inc., a privately-held leading provider of outpatient dialysis services, today announced that it has entered into definitive agreements with respect to the financing of its cash tender offer to acquire all of the outstanding shares of common stock of Dialysis Corporation of America as contemplated by the debt commitment letter with RBC Capital Markets, dated as of April 13, 2010.

25 May 2010

Rockwell Medical's SFP Phase IIb data accepted for presentation at XLVII ERA-EDTA Congress

Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD), and iron deficiency anemia, announced today that Phase IIb data for its lead drug candidate Soluble Ferric Pyrophosphate (SFP) have been accepted for presentation at the XLVII European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Congress, organized in collaboration with the Deutsche Gesellschaft fur Nephrologie (DGfN) in Munich, Germany, June 25-28, 2010.

25 May 2010

La Jolla Pharmaceutical announces $16.3 million private placement

La Jolla Pharmaceutical Company announced today that the Company has entered into definitive agreements with institutional investors and affiliates for a private placement of common stock, convertible preferred stock and warrants to purchase convertible preferred stock totaling up to $16.3 million in gross proceeds.

25 May 2010

YesDTC acquires DRTV marketing rights to patented MediPendant medical alarm device

YesDTC Holdings, Inc., a direct-to-consumer global distributor and marketer of consumer goods and products, announced today, the Company has acquired the rights to market the patented MediPendant™ medical alarm device from Medical Alarm Concepts Holding, Inc. via direct response television (DRTV).

25 May 2010

HHS 'special mailing' on health law's immediate Medicare benefits sparks GOP grumbles

CQ HealthBeat: "Education or propaganda? Or 'beyond propaganda?' The Centers for Medicare and Medicaid Services announced Monday that it will soon send Medicare beneficiaries a special mailing on 'the immediate benefits they may see' from the health care overhaul law. Getting accurate information about key provisions of the law will help Medicare enrollees 'to be on the alert for any scams asking for personal information,' explained acting CMS Administrator Marilyn Tavenner in an agency news release Monday.

25 May 2010

Medtronic fiscal year 2010 revenue up 8% to $15.817 billion

Medtronic, Inc. today announced financial results for its fourth quarter and fiscal year ended April 30, 2010.

25 May 2010

Exactech acquires Brighton Partners

Exactech, Inc., a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that the company has acquired Brighton Partners, Inc., the sole source supplier of the direct compression molded polyethylene bearings used exclusively in Exactech's flagship product, the Optetrak® knee replacement system.

25 May 2010

State regulators mull definition of medical loss ratio

News outlets report on efforts to define what will be considered "medical expenses" when it comes to the mandated medical loss ratios in the new health law.

25 May 2010

Stryker, Acuitec form strategic relationship

Stryker’s Communications business unit and Acuitec announced today that they have signed an agreement that will integrate both companies’ technologies within the operating room to provide customers with a comprehensive offering that combines in-room integration with desirable workflow solutions.

From Stryker 25 May 2010

Experts question 'doc fix' as Reid threatens weekend work on bill with COBRA, Medicare provisions

Politico: Experts are questioning the virtues of the three-year Medicare "doc fix" that would stave off cuts to Medicare doctors' pay but set up a larger fight down the road. ... In health policy circles, the 'doc fix' has become emblematic of Washington's worst habits: a potentially solvable policy problem run amok for about a decade now, bogged down in pure politics and accounting gimmicks. The 'doc fix,' a last-minute infusion of funds to head off a looming doctor pay cut under Medicare, hits the floor this week via the tax extenders bill ..."

25 May 2010

Five Prime Therapeutics, Fast Forward partner to develop Multiple Sclerosis therapeutic candidate

Five Prime Therapeutics, Inc., a leader in the discovery and development of innovative biologics, and Fast Forward, LLC, a subsidiary of the National Multiple Sclerosis Society, today announced an alliance to fund the development of a FivePrime pre-clinical stage therapeutic candidate for treatment of Multiple Sclerosis (MS). Fast Forward will commit up to $1 million to fund the advancement of the therapeutic candidate.

25 May 2010

DOJ warns hospitals, insurers: Mergers will be scrutinized

The Obama administration warned the health care industry Monday that it "won't hesitate to block mergers that threaten to stifle competition," The Associated Press reports.

25 May 2010

Exiqon, MultiD Analyses partnership leads to advanced GenEx qPCR data analysis program development

Exiqon A/S, a leader in microRNA analysis products and services, and MultiD Analyses AB, a leader in comprehensive software solutions for qPCR data analysis, today announced a Development and Distribution Agreement incorporating a specifically adapted version of the GenEx qPCR analysis software for Exiqon's new microRNA qPCR platform. The agreement allows Exiqon to sell a fully compatible and comprehensive data analysis solution to complete their microRNA qPCR offering.

25 May 2010

MAQUET Cardiovascular commences enrollment in trial of FUSION and FUSION BIOLINE Vascular Grafts

MAQUET Cardiovascular LLC today announced enrollment of the first patient in FINEST (FUSION Vascular Graft, FUSION Vascular Graft with BIOLINE and EXXCEL SOFT ePTFE). This prospective, randomized, single-blind, three-arm, parallel group, multi-center study is evaluating the safety and efficacy of MAQUET's investigational FUSION Vascular Graft and FUSION BIOLINE Vascular Graft, compared with its commercially available EXXCEL Soft ePTFE Vascular Graft in peripheral artery bypass surgery.

25 May 2010

Valocor Therapeutics acquires, licenses dermatology therapeutic programs from QLT

Valocor Therapeutics, Inc., a newly formed company focused on the development of innovative therapies for the treatment of dermatologic conditions, today announced the acquisition and license of certain dermatology therapeutic programs from QLT Inc.. This transaction was facilitated by a seed financing for Valocor led by the Working Opportunity Fund, which is managed by GrowthWorks Capital Ltd.

25 May 2010

T2 Biosystems raises $15 million to accelerate development of next generation diagnostic platform

T2 Biosystems, Inc., a company developing the first decentralized clinical diagnostic solution that eliminates extensive sample preparation and enables rapid molecular and immunodiagnostic testing on a single instrument, today announced that it has raised approximately $15 million in a Series C financing. Proceeds from the financing will be used to accelerate the development and commercialization of T2 Biosystems' next generation diagnostic platform for use in the decentralized setting.

25 May 2010

CoDa Therapeutics reports positive results from Phase 2 study of NEXAGON for chronic venous leg ulcers

CoDa Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics for wound care and tissue repair, today announced positive results from its Phase 2 NOVEL Study of NEXAGON® in patients with chronic venous leg ulcers. NEXAGON® is a topically applied, novel therapeutic candidate, with the potential to revolutionize the wound healing treatment paradigm by leveraging a new mechanism and target involved in the healing process.

25 May 2010

Emdeon introduces Office EZBill solution

Emdeon Inc., a leading provider of healthcare revenue and payment cycle management solutions, today announced the launch of a free service available through its Emdeon Office solution. Healthcare providers will now have the ability to submit workers' compensation and automobile medical bills and related attachments electronically through the Emdeon Office EZBill solution regardless of which practice management software they are currently using.

25 May 2010

Medical News

Applied Spine Technologies awarded U.S. patents for 'Dynamic Spine Stabilizer' and 'Spring Junction'

KHN Consumer column: Insuring your health – College student health plans often get low marks

U.S. Renal Care announces definitive agreements to acquire Dialysis Corporation of America

Rockwell Medical's SFP Phase IIb data accepted for presentation at XLVII ERA-EDTA Congress

La Jolla Pharmaceutical announces $16.3 million private placement

YesDTC acquires DRTV marketing rights to patented MediPendant medical alarm device

HHS 'special mailing' on health law's immediate Medicare benefits sparks GOP grumbles

Medtronic fiscal year 2010 revenue up 8% to $15.817 billion

Exactech acquires Brighton Partners

State regulators mull definition of medical loss ratio

Stryker, Acuitec form strategic relationship

Experts question 'doc fix' as Reid threatens weekend work on bill with COBRA, Medicare provisions

Five Prime Therapeutics, Fast Forward partner to develop Multiple Sclerosis therapeutic candidate

DOJ warns hospitals, insurers: Mergers will be scrutinized

Exiqon, MultiD Analyses partnership leads to advanced GenEx qPCR data analysis program development

MAQUET Cardiovascular commences enrollment in trial of FUSION and FUSION BIOLINE Vascular Grafts

Valocor Therapeutics acquires, licenses dermatology therapeutic programs from QLT

T2 Biosystems raises $15 million to accelerate development of next generation diagnostic platform

CoDa Therapeutics reports positive results from Phase 2 study of NEXAGON for chronic venous leg ulcers

Emdeon introduces Office EZBill solution

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News